Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions Patients who have plateaued on a single-agonist GLP-1 and want to escalate under supervision People for whom faster onset and higher trial averages are clinically appropriate Personal or family history of medullary thyroid carcinoma or MEN 2 Pregnancy, breastfeeding, or planning pregnancy Active pancreatitis or untreated severe gastrointestinal disease Expected Timeline What to Expect Tirzepatide tends to act faster and reach further than single-agonist GLP-1s
Most of the time, patients pay: Semaglutide: $134$189 per month Tirzepatide: $219$310 per month Because pricing can change, we confirm your exact cost before your order is processed
The options may be chosen on the product page Quick View Out of Stock Price range: $36.90 through $489.60 This product has multiple variants
Knudsen LB, Secher A, Hecksher-Srensen J, et al
Background and aims: We previously showed that HbA1c testing frequency/pattern link to diabetes control
)
